NCT07209137已完成不适用
A Single-Group Clinical Trial to Evaluate the Effects of Health Nag's BioActive Collagen Jelly on Skin, Hair, Nail, and Joint Health
Nag Food Supplement Trading LLC2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年4月1日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- Change in Skin and Hair Health Assessed by Dermatologist Evaluation
研究概览
简要总结
This decentralized, single-arm, open-label study evaluates the effects of Health Nag's BioActive Collagen Jelly on skin, hair, nail, and joint health in 40 female participants over 12 weeks. Participants will submit online questionnaires and standardized digital photos, which will be analyzed by dermatology experts.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 55 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Be female
- •Be aged 30-
- •Anyone who has concerns surrounding their skin health and appearance over the last four weeks.
- •Anyone who has concerns surrounding their hair health and hair fall or thinning over the last four weeks.
- •Anyone who has been using the same hair and skincare routine and products for at least one month prior to the study, i.e., shampoo, conditioner, products, cleanser, toner, and makeup remover.
- •Anyone willing to maintain the same hair and skincare routine and products throughout the 6-month trial, i.e., shampoo, conditioner, products, cleanser, toner, and makeup remover.
- •Is willing to discontinue any other supplements or herbal remedies that target skin or hair health including but not limited to collagen.
- •Anyone willing to avoid introducing any other supplements, medications, or herbal remedies for the duration of the trial.
- •Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
- •Resides in the United States.
- •Not currently partaking in another research study and will not be partaking in any other research study for the next 6 months and at any point during this study's duration.
- •Anyone who owns a smartphone or camera.
排除标准
- •Anyone unwilling to follow the study protocol
- •Anyone who is planning to undergo facial treatments during the study period, including botox, dermal filler, chemical peels, etc.
- •Anyone who has undergone chemical treatments to the hair in the last three months e.g., chemical straightening, hair extensions with chemical bonding, perms, and relaxers.
- •Anyone with planned chemical treatments to the hair during the study period, e.g., chemical straightening, hair extensions with chemical bonding, perms, and relaxers.
- •Anyone currently taking any prescription medication for hair loss.
- •Anyone who has undergone any surgeries or invasive treatments in the last six months or is planning to undergo any surgeries or invasive treatments during the study.
- •Anyone who has had any major illness in the last three months.
- •Anyone who has any conditions that could affect the hair or scalp (e.g., alopecia areata)
- •Anyone who has stopped using hormonal birth control within the past month.
- •Anyone who has any chronic skin conditions on the face (e.g., eczema or psoriasis).
- •Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
- •Anyone with any allergies or sensitivities to any of the study product ingredients.
- •Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
- •Anyone who is vegan and/or does not consume animal products for any reason.
- •Anyone with a history of substance abuse.
结局指标
主要结局
Change in Skin and Hair Health Assessed by Dermatologist Evaluation
时间窗: Baseline to Week 12
Assessment of changes in skin and hair health from baseline to Week 12 based on standardized digital photographs evaluated by a dermatologist.
次要结局
- Change in Participant-Reported Nail Strength, Joint Mobility, and Well-Being(Baseline, Week 2, Week 4, Week 8, and Week 12)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
1 期
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic CancerPancreatic CancerNCT06758544Guangdong Provincial People's Hospital18
招募中
2 期
Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative ResectionCarcinoma, HepatocellularNCT06454578Qilu Hospital of Shandong University30
已完成
不适用
Clinical study to evaluate the safety and efficacy of a cream in reducing skin pigmentation in healthy pregnant females and lactating females with Mild to Moderate Melasma.CTRI/2022/08/044646Zydus Wellness Ltd50
终止
4 期
Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPHPrimary Pulmonary Arterial HypertensionChronic Thromboembolic Pulmonary HypertensionNCT04954742Heidelberg University30
进行中（未招募）
不适用
A single arm, open-label trial assessing the effect of Capecitabine (Xeloda®) on progression-free survival rate at four months in breast cancer patients with CNS progression after whole brain radiotherapy - RADEXEUCTR2008-007350-35-FRROCHE